Agios Pharmaceuticals IncのBeta
Agios Pharmaceuticals IncのBetaは何ですか。
Agios Pharmaceuticals IncのBetaは1.08です。
Betaの定義は何ですか。
BETAは、株式が市場全体よりも多かれ少なかれ揮発性であるかどうかを示します。 1未満のベータは株式が市場よりも揮発性が低いことを示し、1より大きいベータは株式がより揮発性であることを示します。ボラティリティは、平均値周辺の価格の変動として測定されます。
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
NASDAQのセクタHealth CareにおけるBetaの企業と比べるAgios Pharmaceuticals Inc
Agios Pharmaceuticals Incは何をしますか。
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Agios Pharmaceuticals Incと類似のbeta
- Simmons First NationalのBetaは1.08です。
- BTCSのBetaは1.08です。
- Annaly Capital Management IncのBetaは1.08です。
- Pan American SilverのBetaは1.08です。
- Lovable LingerieのBetaは1.08です。
- Town Centre Securities PLCのBetaは1.08です。
- Agios Pharmaceuticals IncのBetaは1.08です。
- The Sherwin-WilliamsのBetaは1.08です。
- Euronet Worldwide IncのBetaは1.08です。
- Rockwealth ResourcesのBetaは1.08です。
- Pan OrientのBetaは1.08です。
- Pan OrientのBetaは1.08です。
- The Karur Vysya BankのBetaは1.08です。